Diabetes and Weight Loss Ozempic (semaglutide) is a medication used to treat type 2 diabetes by helping to control blood sugar levels
In SUMMIT, tirzepatide reduced the composite of cardiovascular death or worsening heart-failure events by 38% (HR 0.62, 95% CI 0.410.95) and worsening HF events alone by 46% (HR 0.54, 95% CI 0.340.85), with a +6.9-point between-group improvement in the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS), an 18-meter improvement in 6-minute walk distance (6MWD), and a placebo-adjusted weight loss of 11.6% [5]
CJC-1295: The GHRH Signal First, we have CJC-1295 (without DAC)
These choices are often based on personal experience rather than clinical evidence, making provider guidance important
However, its important to note that outcomes are significantly better when semaglutide is combined with lifestyle changes such as improved nutrition and regular physical activity